Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $14.9 Million - $17.6 Million
-276,112 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $15.3 Million - $16.8 Million
276,112 New
276,112 $16.6 Million
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $2.34 Million - $3.18 Million
-62,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $454,322 - $539,922
10,700 Added 20.86%
62,000 $3.09 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $2.3 Million - $2.61 Million
-57,418 Reduced 52.81%
51,300 $2.29 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $2.11 Million - $2.55 Million
59,318 Added 120.08%
108,718 $4.4 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $1.39 Million - $1.56 Million
-37,600 Reduced 43.22%
49,400 $1.88 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $2.87 Million - $3.19 Million
87,000 New
87,000 $3.04 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.